Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 3, 2013, Pages 232-238

  Nichols, Elizabeth M ^a   Feigenberg, Steven Joel ^a   Marter, Kimberly ^a   Cheston, Sally B ^a   Lasio, Giovanni ^a   Tkaczuk, Katherine ^b   Kesmodel, Susan ^c   Buras, Robert ^c   Regine, William F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Medical Oncology ^*  (United States)

^c Surgical Oncology   (United States)

Author keywords

APBI; early stage breast cancer; preoperative

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HEART; HUMAN; LUNG; PARTIAL MASTECTOMY; PREOPERATIVE RADIOTHERAPY; SKIN; THORAX WALL; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 84878843431     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182467ffd     Document Type: Article

References (30)

1. Nattinger AB, Kneusel RT, Hoffmann RG, et al. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst. 2001;93:1344-1346.
2. Nattinger AB, Hoffmann RG, Kneusel RT, et al. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356:1148-1153.
3. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513-520.
4. Bentzen SM, Agrawal RK, Aird EG, et al. The UK standardization of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet Oncol. 2008a;9:331-341.
5. Bentzen SM, Agrawal RK, Aird EG, et al. The UK standardization of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet. 2008;371:1098-1107.
6. A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. National Surgical Breast and Bowel Project, Protocol B-39. Available at: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails. aspx?study=0413.
7. Offersen BV, Overgaard M, Kroman N, et al. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 2009; 90:1-13.
8. Nichols EM, Dhople AA, et al. Comparative analysis of the postlumpectomy target volume versus the use of pre-lumpectomy tumor volume for early stage breast cancer: implications for the future. Int J Radiat Oncol Biol Phys. 2010;77:197-202.
9. Berg WA, Gutierrez L, et al. Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233: 830-849.
10. Vicini FA, Winter K, Straube W, et al. Initial efficacy results of RTOG 0319: three dimensional conformal therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Bio Phys. 2008;72(1, suppl):83.
11. Faverly D, Burgers L, Bult P, et al. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Sem Diagn Pathol. 1994;11:193-198.
12. Clark RM, Wilkinson RH, Miceli XX, et al. Breast cancer: experiences with conservation therapy. Am J Clin Oncol (CCT). 1987;10:461-468.
13. Scanderbeg D, Yashar C, White G, et al. Evaluation of three APBI techniques under NSAPB B-39 guidelines. J Appl Clin Med Phys. 2009;11:3021.
14. Bovi J, Qi XS, White J, et al. Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. Radiother Oncol. 2007;84:226-232.
15. Kirby AM, Evans PM, Nerurkar AY, et al. How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume definition for partial-breast radiotherapy? Radiother and Oncol. 2010;94: 292-299.
16. Kirby AM, Coles CE, Yarnold JR. Target volume definitions for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches. Radiother Oncol. 2010;94:255-263.
17. Hanbeukers B, Borger J, Van den Ende P, et al. Customized computed tomography-based boost volumes in breast-conserving therapy: use of three-dimensional histologic information for clinical target volume margins. Int J Radiat Oncol Biol Phys. 2009;75:757-763.
18. Hepel JT, Tokita M, MacAusland SG, et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75: 1290-1296.
19. Jagsi R, Ben-David MA, Moran JM, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76:71-78.
20. Chen PY, Wallace M, Mitchell C, et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76: 991-997.
21. Wolmark N, Curran WJ. Response to "unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation". Int J Radiat Oncol Biol Phys. 2010;76:71-78.
22. Wolmark N, Curran WJ. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75:1290-1296.
23. Wolmark N, Curran WJ, Vicini F, et al. Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partialbreast irradiation" (Int J Radiat Oncol Biol Phys. 2010;76:71-78)
24. "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" (Int J Radiat Oncol Biol Phys. 2009;75:1290-1296).
25. Int J Radiat Oncol Biol Phys. 2010; 77:317, author reply 318.
26. Bartelink H, Horior JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259-3265.
27. Julian TB, et al. Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial. J Clin Oncol. 2011;29(15S):82s.
28. Suh WW, Pierce LJ, Vicini FA, et al. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Bio Phys. 2005;62:790-796.
29. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
30. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235-2241.